# CC-5013 in Treating Patients With Recurrent Glioma

> **NCT00036894** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00036894
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036894, "CC-5013 in Treating Patients With Recurrent Glioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00036894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*